Scientists report they have come up with a new treatment for children with brain tumors called medulloblastomas. Children with the high-risk tumors have a low 30-40 percent chance of surviving and living to the age of 5 and chemotherapy can take as long as a year.

But, Dr. Amar Gajjar of St. Jude’s Children’s Research Hospital in Memphis says using a patient’s own stem cells is having an amazing effect in treating the cancer.

Dr. Gajjar says, not only they can now cure about 70 percent of children with high-risk medulloblastoma, they can also cure more than 80 percent of those with standard-risk disease with a shorter, and therefore more convenient, chemotherapy approach.

The research team’s results appear in the latest issue of The Lancet Oncology.

Link


  • Umbilical Cord Blood Transplants Successful in Children with High-Risk Acute Lymphocytic Leukemia
  • Umbilical Cord Blood Holds Clue to Childhood Allergies
  • Children With Rare Neurogenerative Disorder Will Undergo Phase I Clinical Trial Using Stem Cells
  • Reovirus Used To Eliminate Cancer Cells From Autologous Stem Cell Transplants
  • The Truth Behind Stem Cell Research & Veto
  • Stem-Cell Trial for Neurodegenerative Pediatric Disease
  • Genetically Designed Embryonic Stem Cells Lead To Better Brain Treatment
  • Trial for Purified Neural Stem Cell Transplantation Begins
  • AML (Cancer) Treatment With Allogeneic Stem Cell Transplants Shows Strong Promise in Adults
  • High Doses of Alcohol Could Destroy Stem Cells